TESK2 and breast carcinoma: A kinase previously not linked to breast cancer subtypes, TESK2, also showed a trend for more frequently harboring an HFI SNP (rs17853159) in TNBC compared to ER+cancers (16% vs 3%, P-unadjusted = 0.06).